[koheripbal]

Clinicians more-or-less agree that Remdesivir has some minor beneficial anti-viral impact if given at the earliest moments of infection (like within 12 hours of infection), and some lesser beneficial impact later in cases where the body has trouble getting rid of the virus.

Covid-19 doesn't kill you. Those most sick in their 2nd and 3rd weeks are usually made very sick by their immune system's own inflammatory immune response (cytokine storm).

What this means is that Remdesivir could be very effective for patients that have known exposures and are in high risk categories.

...but, for most clinicians, since it needs to be given intravenously, it's not usually part of the clinical response (for the moment).

This is why the manufacturer (Gilead) is working on an oral delivery system. ...and we should all be supportive of that, because a broad use anti-viral might be very useful for covid-19 as well as other future viral diseases.

Still - what's going to save us from covid-19 is going to be a vaccine (and some degree of herd immunity).